International Patent: PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PERIODONTAL DISEASE COMPRISING GPR40 AGONIST

GENEVA, Oct. 22 -- EFLASK CO., LTD. filed a patent application (KR2026/095886) for “PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PERIODONTAL DISEASE COMPRISING GPR40 AGONIST”. With publication no. WO/2026/221433, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/506

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....